mrjСовременная ревматологияModern Rheumatology Journal1996-70122310-158XIMA-PRESS, LLC10.14412/1996-7012-2016-1-52-55mrj-672Research ArticleНОВОЕ В РЕВМАТОЛОГИИNOVELTY IN RHEUMATOLOGYНестероидные противовоспалительные препараты: что нового в международных публикациях за 2015 г.?Nonsteroidal anti-inflammatory drugs: What is new in international publications in 2015?КаратеевА. Е.KarateevA. E.

115522, Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115552

aekarateev@rambler.ruГонтаренкоН. В.GontarenkoN. V.

115522, Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115552

ЦурганА. В.TsurganA. V.

115522, Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115552

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian Federation2016240320161015255Copyright © Каратеев А.Е., Гонтаренко Н.В., Цурган А.В., 20162016Каратеев А.Е., Гонтаренко Н.В., Цурган А.В.Karateev A.E., Gontarenko N.V., Tsurgan A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://mrj.ima-press.net/mrj/article/view/672

Нестероидные противовоспалительные препараты (НПВП) являются одним из наиболее востребованных современной медициной классов лекарственных препаратов. Ежегодно в российских и зарубежных научных изданиях появляются сотни новых статей, посвященных эффективности и безопасности НПВП. Практикующим врачам порой трудно отслеживать столь большой объем постоянно меняющейся информации. Поэтому мы решили представить вниманию читателей краткий обзор некоторых наиболее интересных, на наш взгляд, и самых новых работ, в которых обсуждаются различные аспекты применения НПВП.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the classes of drugs that are most needed by modern medicine. Hundreds of new articles on the efficiency and safety of NDAIDs are published in Russian and foreign scientific journals every year. It is difficult for the practitioners to keep track of so a large amount of constantly changing information. So we have decided to present to our readers a concise overview of some of the most interesting, in our opinion, and the newest papers that discuss different aspects of using NSAIDs.

нестероидные противовоспалительные препаратыэффективностьбезопасностьnonsteroidal anti-inflammatory drugsefficacysafetyReferencesKroon F, van der Burg LR, Ramiro S, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev. 2015 Jul 17;7:CD010952. doi: 10.1002/14651858.CD010952.pub2.Kroon F, van der Burg LR, Ramiro S, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev. 2015 Jul 17;7:CD010952. doi: 10.1002/14651858.CD010952.pub2.Huscher D, Thiele K, Rudwaleit M, et al. Trends in treatment and outcomes of ankylosing spondylitis in outpatient rheumatological care in Germany between 2000 and 2012. RMD Open. 2015 May 25;1(1):e000033. doi: 10.1136/rmdopen-2014-000033. eCollection 2015.Huscher D, Thiele K, Rudwaleit M, et al. Trends in treatment and outcomes of ankylosing spondylitis in outpatient rheumatological care in Germany between 2000 and 2012. RMD Open. 2015 May 25;1(1):e000033. doi: 10.1136/rmdopen-2014-000033. eCollection 2015.Jones P, Dalziel SR, Lamdin R, et al. Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Database Syst Rev. 2015 Jul 1;7:CD007789. doi: 10.1002/14651858.CD007789.pub2.Jones P, Dalziel SR, Lamdin R, et al. Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Database Syst Rev. 2015 Jul 1;7:CD007789. doi: 10.1002/14651858.CD007789.pub2.Kress H, Baltov A, Basinski A, et al. Acute pain: a multifaceted challenge – the role of nimesulide. Curr Med Res Opin. 2016 Jan;32(1):23-36. doi: 10.1185/03007995. 2015.1100986. Epub 2015 Oct 15.Kress H, Baltov A, Basinski A, et al. Acute pain: a multifaceted challenge – the role of nimesulide. Curr Med Res Opin. 2016 Jan;32(1):23-36. doi: 10.1185/03007995. 2015.1100986. Epub 2015 Oct 15.Yeung M, Jamshidi S, Horner N, et al. Efficacy of Nonsteroidal Anti-Inflammatory Drug Prophylaxis for Heterotrophic Ossification in Hip Arthroscopy: A Systematic Review. Arthroscopy. 2015 Sep 29. pii: S0749-8063(15)00661-1. doi: 10.1016/j.arthro.2015.08.007. [Epub ahead of print]Yeung M, Jamshidi S, Horner N, et al. Efficacy of Nonsteroidal Anti-Inflammatory Drug Prophylaxis for Heterotrophic Ossification in Hip Arthroscopy: A Systematic Review. Arthroscopy. 2015 Sep 29. pii: S0749-8063(15)00661-1. doi: 10.1016/j.arthro.2015.08.007. [Epub ahead of print]Dregan A, Chowienczyk P, Gulliford MC. Are Inflammation and Related Therapy Associated with All-Cause Dementia in a Primary Care Population? J Alzheimers Dis. 2015;46(4):1039-47. doi: 10.3233/JAD-150171.Dregan A, Chowienczyk P, Gulliford MC. Are Inflammation and Related Therapy Associated with All-Cause Dementia in a Primary Care Population? J Alzheimers Dis. 2015;46(4):1039-47. doi: 10.3233/JAD-150171.Friis S, Riis AH, Erichsen R, et al. LowDose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study. Ann Intern Med. 2015 Sep 1;163(5):347-55. doi: 10.7326/M15-0039.Friis S, Riis AH, Erichsen R, et al. LowDose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study. Ann Intern Med. 2015 Sep 1;163(5):347-55. doi: 10.7326/M15-0039.Petrick J, Sahasrabuddhe V, Chan A, et al. NSAID use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Cancer Prev Res (Phila). 2015 Dec;8(12):1156-62. doi: 10.1158/1940-6207.CAPR-15-0126. Epub 2015 Sep 21.Petrick J, Sahasrabuddhe V, Chan A, et al. NSAID use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Cancer Prev Res (Phila). 2015 Dec;8(12):1156-62. doi: 10.1158/1940-6207.CAPR-15-0126. Epub 2015 Sep 21.Wilson D, Schutte S, Abel S. Comparing the Efficacy of Ophthalmic NSAIDs in Common Indications: A Literature Review to Support Cost-effective Prescribing. Ann Pharmacother. 2015 Jun;49(6):727-34. doi: 10.1177/1060028015574593. Epub 2015 Feb 27.Wilson D, Schutte S, Abel S. Comparing the Efficacy of Ophthalmic NSAIDs in Common Indications: A Literature Review to Support Cost-effective Prescribing. Ann Pharmacother. 2015 Jun;49(6):727-34. doi: 10.1177/1060028015574593. Epub 2015 Feb 27.Scheiman J. NSAID-induced Gastrointestinal Injury: A Focused Update for Clinicians. J Clin Gastroenterol. 2016 Jan;50(1):5-10. doi: 10.1097/MCG. 0000000000000432.Scheiman J. NSAID-induced Gastrointestinal Injury: A Focused Update for Clinicians. J Clin Gastroenterol. 2016 Jan;50(1):5-10. doi: 10.1097/MCG. 0000000000000432.Lanas А. Hemorragia gastrointestinal. Gastroenterol Hepatol. 2015 Sep;38 Suppl 1:56-63. doi: 10.1016/S0210-5705(15)30020-0.Lanas А. Hemorragia gastrointestinal. Gastroenterol Hepatol. 2015 Sep;38 Suppl 1:56-63. doi: 10.1016/S0210-5705(15)30020-0.Figueiras A, Estany-Gestal A, Aguirre C, et al. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case-control study. Pharmacogenet Genomics. 2016 Feb;26(2):66-73. doi: 10.1097/FPC.0000000000000186.Figueiras A, Estany-Gestal A, Aguirre C, et al. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case-control study. Pharmacogenet Genomics. 2016 Feb;26(2):66-73. doi: 10.1097/FPC.0000000000000186.Yang M, Wang HT, Zhao M, et al. Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury. Medicine (Baltimore). 2015 Oct;94(40):e1592. doi: 10.1097/MD. 0000000000001592.Yang M, Wang HT, Zhao M, et al. Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury. Medicine (Baltimore). 2015 Oct;94(40):e1592. doi: 10.1097/MD. 0000000000001592.Rogers M, Aronoff D. The Influence of Nonsteroidal Anti-Inflammatory Drugs on the Gut Microbiome. Clin Microbiol Infect. 2015 Oct 16. pii: S1198-743X(15)00902-7. doi: 10.1016/j.cmi.2015.10.003. [Epub ahead of print].Rogers M, Aronoff D. The Influence of Nonsteroidal Anti-Inflammatory Drugs on the Gut Microbiome. Clin Microbiol Infect. 2015 Oct 16. pii: S1198-743X(15)00902-7. doi: 10.1016/j.cmi.2015.10.003. [Epub ahead of print].Long M, Kappelman M, Martin C, et al. Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease. J Clin Gastroenterol. 2016 Feb;50(2):152-6. doi: 10.1097/MCG.0000000000000421.Long M, Kappelman M, Martin C, et al. Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease. J Clin Gastroenterol. 2016 Feb;50(2):152-6. doi: 10.1097/MCG.0000000000000421.Hensley A, Beales IL. Use of CycloOxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study. Pharmaceuticals (Basel). 2015 Sep 7;8(3): 512-24. doi: 10.3390/ph8030512.Hensley A, Beales IL. Use of CycloOxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study. Pharmaceuticals (Basel). 2015 Sep 7;8(3): 512-24. doi: 10.3390/ph8030512.Nagata N, Niikura R, Aoki T, et al. Risk factors for adverse in-hospital outcomes in acute colonic diverticular hemorrhage. World J Gastroenterol. 2015 Oct 7;21(37):10697-703. doi: 10.3748/wjg.v21.i37.10697.Nagata N, Niikura R, Aoki T, et al. Risk factors for adverse in-hospital outcomes in acute colonic diverticular hemorrhage. World J Gastroenterol. 2015 Oct 7;21(37):10697-703. doi: 10.3748/wjg.v21.i37.10697.Paulasir S, Kaoutzanis C, Welch KB, et al. Nonsteroidal Anti-inflammatory Drugs: Do They Increase the Risk of Anastomotic Leaks Following Colorectal Operations? Dis Colon Rectum. 2015 Sep;58(9):870-7. doi: 10.1097/DCR.0000000000000430.Paulasir S, Kaoutzanis C, Welch KB, et al. Nonsteroidal Anti-inflammatory Drugs: Do They Increase the Risk of Anastomotic Leaks Following Colorectal Operations? Dis Colon Rectum. 2015 Sep;58(9):870-7. doi: 10.1097/DCR.0000000000000430.Schjerning Olsen A, Gislason G, McGettigan P, et al. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction. JAMA. 2015 Feb 24;313(8):805-14. doi: 10.1001/jama.2015.0809.Schjerning Olsen A, Gislason G, McGettigan P, et al. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction. JAMA. 2015 Feb 24;313(8):805-14. doi: 10.1001/jama.2015.0809.Chang YK, Liu JS, Hsu YH, et al. Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal AntiInflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study. Medicine (Baltimore). 2015 Sep;94(38):e1362. doi: 10.1097/MD. 0000000000001362.Chang YK, Liu JS, Hsu YH, et al. Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal AntiInflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study. Medicine (Baltimore). 2015 Sep;94(38):e1362. doi: 10.1097/MD. 0000000000001362.Patel DP, Schenk JM, Darke A, et al. Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial. BJU Int. 2015 Aug 25. doi: 10.1111/bju.13264. [Epub ahead of print].Patel DP, Schenk JM, Darke A, et al. Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial. BJU Int. 2015 Aug 25. doi: 10.1111/bju.13264. [Epub ahead of print].

The authors declare that there are no conflicts of interest present.